Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.
Press releases published on July 24, 2025

Rezolve Announces $50 Million Private Placement with Two New Fundamental Long Hold Institutional Investors
NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the company reinventing retail through real-time AI-driven consumer engagement, today announced that it has entered into definitive agreements with two new fundamental long hold …

Princeton Athletics partners with vivenu to modernize ticketing experience
DÜSSELDORF, Germany and PRINCETON, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Princeton University and vivenu have announced a new partnership to elevate the ticketing experience across campus. By adopting vivenu’s advanced ticketing technology, Princeton …

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025
STOUGHTON, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report second quarter 2025 financial results before the market opens on Thursday, August 7, 2025. Following the release of the …

BigCommerce Launches B2B Quick Start Accelerator to Help Merchants Go Live Faster and Grow Sooner
AUSTIN, Texas, July 24, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading open SaaS ecommerce platform for B2B and B2C businesses, today announced the launch of the B2B Quick Start Accelerator, a partner-led implementation program built to …

NowVertical to Attend Qlik AI Reality Tour, Deepening Strategic Partnerships and Showcasing AI Leadership
TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) (“NowVertical” or the “Company”), a leading data and AI solutions provider, is pleased to announce its participation in the Qlik AI Reality Tour event in São Paulo, Brazil on …

ModelOp Transforms Enterprise AI Governance with Launch of the First Agentic AI Chat Interface and Controls for Agentic AI
CHICAGO, July 24, 2025 (GLOBE NEWSWIRE) -- ModelOp, the leading AI lifecycle automation and governance software for enterprises, announced today the launch of the world’s first comprehensive toolset for governing Agentic AI. The roll out marks a …

Lipovive: Official Launch of Natural Weight Loss Supplement for Better Metabolic Health
New York City, NY, July 24, 2025 (GLOBE NEWSWIRE) -- Lipovive: Official Launch of a Revolutionary Weight Loss Supplement The official launch of Lipovive, a new and groundbreaking weight loss supplement, marks a significant milestone in the world of natural …

The Pink Salt Trick Recipe for Fast Weight Loss Trend in 2025: Why LipoVive Is the Research-Backed Alternative
Albany, New York, July 24, 2025 (GLOBE NEWSWIRE) -- A trending pink salt recipe is sweeping TikTok as a supposed shortcut for weight loss. But what’s really behind this viral drink, and why are experts raising concerns? In this report, we break down the …

MemoCore Drops – Official Launching Ultimate Cognitive Health Supplement for Memory and Focus
New York City, NY, July 24, 2025 (GLOBE NEWSWIRE) -- MemoCore Drops Launches as a Cognitive Support Supplement to Enhance Memory and Mental Clarity in 2025 Today marks the official launch of MemoCore Drops, a newly developed cognitive support supplement …

Zefiro Subsidiary P&G Secures Award for Well-Plugging Project Near Columbus, Ohio
FORT LAUDERDALE, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) is pleased to announce that its subsidiary Plants …

Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases
Matchpoint to receive up to $60 million in upfront payment and research funding, with up to $1 billion in total potential payments, including option exercise fee, development and commercial milestones Matchpoint will lead all research activities through …

Alumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus Erythematosus
-Topline Readout Expected in Q3 2026- SOUTH SAN FRANCISCO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today …

NETCLASS TECHNOLOGY INC Establishes a Singapore Subsidiary to Drive Global AI Business Expansion
SHANGHAI and HONG KONG, July 24, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, today announced the …

Regeneron Announces the 2025 Winners of the Regeneron Prize for Creative Innovation
TARRYTOWN, N.Y., July 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 13th annual Regeneron Prize for Creative Innovation (the “Regeneron Prize”), which recognizes and rewards outstanding …

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study
– Peer-reviewed publication in Annals of Clinical and Translational Neurology highlights the use of the MSA Atrophy Index developed to diagnose and track disease progression in Multiple System Atrophy – MELBOURNE, Australia and SAN FRANCISCO, July 24, 2025 …

Quality Clouds Launches AI Quality Shield for Technology Services Companies to Empower Enterprise Clients with AI Readiness and Orchestration
LONDON, July 24, 2025 (GLOBE NEWSWIRE) -- Quality Clouds, a provider of software governance solutions trusted by companies like JPMorgan Chase, Shell, Barclays, and BP, today announced the launch of AI Quality Shield, a new governance suite designed to …

Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025
JUPITER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report second quarter 2025 financial results on Thursday, August 7, 2025. The company will hold a conference call beginning at …

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference
Boca Raton, July 24, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) announced today that additional analyses from its Phase 2 MINDFuL trial evaluating XPro™, a novel selective soluble TNF inhibitor, will be released in an oral presentation at the …

Xtract One Secures SmartGateway Contract with Global Performing Arts Company Famous for Live Entertainment
TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway screening solution has been chosen by a leading, global performing arts company, known …

TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities
SAN FRANCISCO, July 24, 2025 (GLOBE NEWSWIRE) -- TCG Labs Soleil, a venture firm integrating dedicated capital with an in-house biotech R…